• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.10% Nasdaq Down 1.82%

    Cytori Therapeutics, Inc. (CYTX)

    -NasdaqCM
    0.14 Down 0.04(21.87%) 4:00PM EST
    Prev Close:0.18
    Open:0.16
    Bid:0.10 x 2800
    Ask:0.40 x 400
    1y Target Est:2.42
    Beta:3.48407
    Earnings Date:Mar 10 - Mar 14 (Est.)
    Day's Range:0.14 - 0.17
    52wk Range:0.14 - 1.47
    Volume:4,388,248
    Avg Vol (3m):1,728,210
    Market Cap:27.30M
    P/E (ttm):N/A
    EPS (ttm):-0.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTX

    Comparison

    Symbol% ChgMkt Cap
    CYTXDown 21.87%27.30M
    BAXDown 3.97%19.69B
    OSIRDown 2.50%214.64M
    ASTM 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.36
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.19
    Quarterly EPS Est (Dec-15) :-0.04
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, includin... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback